Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06396650 · ClinicalTrials.gov registry record · NA
Assessment of Fall Risks and Subject-specific Training for Fall Reduction
A NA study of Fall Risk, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06396650: Recruiting NA study of Fall Risk, sponsored by University of Maryland, Baltimore.
NCT06396650 is a NA study of Fall Risk that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 40 participants, below the 73-participant average among 3 other Fall Risk trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06396650, a NA study of Fall Risk, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The target population of this project is older people with high risks of falls. About 30% community-dwelling individuals over 65 years of age fall each year and the rate of fall related injuries leading to loss of function and independence increases with age. Falls are the leading cause of fatal and non-fatal injuries and the leading cause traumatic brain injury in older adults. Slip-related falls in older adults comprise 40% of outdoor falls and are the leading cause of hip fracture or traumatic head injury. In 2012, 2.4 million non-fatal falls were treated in emergency room visits with $30 billion dollars spent on direct medical costs. In addition to fractures and traumatic brain injury, nonfatal falls frequently lead to reduced levels of activity, fear of falling, and reduced quality of life. Clearly, advancing the predictive, preventative, and rehabilitative methods aimed at reducing the risk of injurious falls in this population is imperative. Although falls are multi-factorial in nature, there has been few individualized assessment of the biomechanical causes of falls. The purpose of this study is to conduct subject-specific training on older adults with fall risks with combined home-hospital rehabilitation. This project will involve rehabilitation interventions based on the characteristics of falling patterns and older adults with reduced capability controlling the balance. To conduct subject-specific fall prevention training. based on identified individual fall mechanisms.
Primary Outcome
Berg Balance Scale (BBS) evaluation will be used which provides a value for fall risks assessment.
Conditions Studied
Interventions
- DEVICE Home-based training
- DEVICE Lab-based training
Study Locations (1)
Maryland
- University of Maryland Baltimore - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2029-04-30 |
| Phase | NA |
What NCT06396650 shows while recruiting
NCT06396650 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 73-participant average among 3 other Fall Risk trials with a reported enrollment target (45% lower).
The record links to 1 condition, with Fall Risk appearing as the primary indexed condition, and to 2 interventions - of which Home-based training is the first listed.
NCT06396650 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06396650 about?
NCT06396650 is a clinical study titled "Assessment of Fall Risks and Subject-specific Training for Fall Reduction". The target population of this project is older people with high risks of falls. About 30% community-dwelling individuals over 65 years of age fall each year and the rate of fall related injuries leading to loss of function and independence increases with age. Falls are the leading cause of fatal and...
What is the current status of trial NCT06396650?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-12-01. Estimated completion is 2029-04-30.
What conditions does trial NCT06396650 study?
This clinical trial studies the following conditions: Fall Risk.
What interventions are being tested in trial NCT06396650?
The interventions under investigation include: Home-based training (DEVICE), Lab-based training (DEVICE).
Who is sponsoring clinical trial NCT06396650?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06396650 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fall Risk
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI